TABLE 2.

Subject disposition

Reason subjects discontinued study drugsNo. of subjects (%)
d4T-3TC-IDVAZT-3TC-IDV
Before wk 8015 (18)24 (28)
    Lost to follow-up1 (1)1 (1)
    Death2 (2)0
    Adverse events7 (8)11 (13)
    Subject request2 (2)3 (4)
    Virological failure1 (1)6 (7)
    Physician decision01 (1)
    Other reason or unknown2 (2)2 (2)
During the extended follow-up9 (16)13 (22)
    Lost to follow-up01 (2)
    Death1 (2)0
    Adverse events4 (7)0
    Subject request04 (7)
    Virological failure00
    Physician decision3 (5)2 (3)
    Other reason or unknown1 (2)6 (10)